These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 3496652

  • 1. [Localized scleroderma: clinical and laboratory study of 11 cases].
    Martins RW, Missi SM, Sampaio Sde O, Pereira RM, Yoshinari NH.
    Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(6):278-81. PubMed ID: 3496652
    [No Abstract] [Full Text] [Related]

  • 2. [Demonstration of antinuclear factors using indirect immunofluorescence in scleroderma patients].
    Nebe H, Blume N.
    Dermatol Monatsschr; 1971 Jan; 157(1):27-31. PubMed ID: 4938251
    [No Abstract] [Full Text] [Related]

  • 3. Proceedings: Serologic abnormalities and their significance in localized scleroderma.
    Scarola JA, Shulman LE.
    Arthritis Rheum; 1975 Jan; 18(5):526. PubMed ID: 1081397
    [No Abstract] [Full Text] [Related]

  • 4. Juvenile linear scleroderma associated with serologic abnormalities.
    Woo TY, Rasmussen JE.
    Arch Dermatol; 1985 Nov; 121(11):1403-5. PubMed ID: 3876808
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical cases and laboratory data in a group of mesenchymopathies: lupus erythematosus, dermatomyositis, scleroderma].
    Meneghini CL, Bonifazi E.
    J Med Lyon; 1972 Sep 05; 53(232):1123-31. PubMed ID: 4539165
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Progressive facial hemiatrophy: central nervous system involvement and relationship with scleroderma en coup de sabre.
    Blaszczyk M, Królicki L, Krasu M, Glinska O, Jablonska S.
    J Rheumatol; 2003 Sep 05; 30(9):1997-2004. PubMed ID: 12966605
    [Abstract] [Full Text] [Related]

  • 16. [The boundary levels of laboratory data in autoimmune diseases].
    Watanabe H, Imafuku Y, Ono S, Honda S, Yoshida H.
    Rinsho Byori; 1993 Jun 05; 41(6):637-41. PubMed ID: 8361029
    [Abstract] [Full Text] [Related]

  • 17. Immunologic response to blood group substance in scleroderma.
    Stringa SG, Avalos JC, Andrada JA, Casala A, Bianchi C.
    Arch Dermatol; 1971 Apr 05; 103(4):394-9. PubMed ID: 4103900
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.